Status:
COMPLETED
Influence of Sirolimus and MMF on Vascular Function and Markers of Cellular Function in Renal Transplant Recipients
Lead Sponsor:
University Hospital Muenster
Collaborating Sponsors:
Else Kröner Fresenius Foundation
Conditions:
Renal Transplantation
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
Chronic transplant nephropathy and cardiovascular death are the main reasons for loss of transplanted organs after kidney transplantation. Vascular changes, induced by hypertension and/or immunologic...
Detailed Description
Cardiovascular complications and chronic rejection are chief causes of transplant loss\[1,2\]. After renal transplantation patients are still characterized by their pre-existing arteriosclerotic chang...
Eligibility Criteria
Inclusion
- renal transplantation stable function
Exclusion
- acute rejection
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2010
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00204321
Start Date
June 1 2005
End Date
January 1 2010
Last Update
January 13 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UKM
Münster, North Rhine-Westphalia, Germany, 48149